XERS
$2.04
Xeris Pharmaceuticals
$.04
2.00%
XERS
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  ($0.22)
Revenue:  $20.67 Mil
Wednesday
Feb 9
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when XERS reports earnings?
Beat
Meet
Miss

Where is XERS's stock price going from here?
Up
Flat
Down
Stock chart of XERS
Analysts
Summary of analysts' recommendations for XERS
Score
Grade
Pivots
Resistance
$2.16
$2.11
$2.07

$2.02

Support
$1.98
$1.93
$1.89
Tweet
Growth
Description
Xeris Pharmaceuticals, Inc. produces peptides, proteins, antibodies, molecules, auto-injectors, multi-dose pens and infusion pumps to treat endocrine and metabolic diseases. The company's proprietary formulation technologies consist of XeriSol (TM) and XeriJect(TM). Xeris Pharmaceuticals, Inc. is based in Chicago, United States.